 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Reprints |
| Permissions |
| Cite this article as |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEWS
Panminerva Medica 2016 March;58(1):86-93
Copyright © 2016 EDIZIONI MINERVA MEDICA
language: English
Impact of metabolic comorbidities on outcomes of patients with acute pancreatitis: a scoping review
Rachel L. GOODGER, Varsha M. ASRANI, John A. WINDSOR, Maxim S. PETROV ✉
Department of Surgery, University of Auckland, Auckland, New Zealand
With the increasing prevalence of metabolic comorbidities, their impact on outcomes of patients with acute pancreatitis needs to be considered. Metabolic comorbidities, such as diabetes mellitus, obesity, and metabolic syndrome, have been shown to have a role to play in the course of disease. This scoping review aims to map published clinical studies that have investigated the impact of metabolic comorbidities on outcomes in patients with acute pancreatitis.